Posted: Fri Nov 11, 2005 11:22 pm
http://lewiston.mit.edu/sleep/ApneaNEJM1.pdfDan01 wrote:Do you have a link?
http://lewiston.mit.edu/sleep/ApneaNEJM1.pdfDan01 wrote:Do you have a link?
Several studies have demonstrated that airway pressurization (the main medical therapy for the
syndrome) can reverse hypercoagulability 34 35 and hemodynamic changes 38-42 and even reduce the risk of cardiovascular events.25 The present study was not designed or powered to address adherence with treatment or the effect of treatment on outcomes. Nonetheless, our study demonstrated an increased risk of stroke or death from any cause among patients with the obstructive sleep apnea syndrome despite the administration of various therapies. Several explanations may account for this finding. First, it is likely that many of our patients had had untreated obstructive sleep apnea for years before seeking treatment, resulting in a prolonged
exposure to cardiovascular risk. The median 3.4 years of follow-up may not have been a sufficient length of time to derive the potential cardiovascular therapeutic benefits. Second, reduced compliance with continuous positive airway pressure and limited efficacy of other treatments may have played a role in the failure of therapy to reduce the risk to baseline levels. Third, in contrast to the patients in a recent study that suggested a beneficial effect of treatment on outcomes, 25 our population was older and had a higher prevalence of cardiovascular risk factors.
What bugs me is that they say: "Nonetheless, our study demonstrated an increased risk of stroke or death from any cause among patients with the obstructive sleep apnea syndrome despite the administration of various therapies."excerpts from The New England Journal of Medicine [size=150]Obstructive Sleep Apnea as a Risk Factor for Stroke and Death [/size]by H. Klar Yaggi, M.D., M.P.H., John Concato, M.D., M.P.H., Walter N. Kernan, M.D., Judith H. Lichtman, Ph.D., M.P.H., Lawrence M. Brass, M.D., and Vahid Mohsenin, M.D wrote:
Many patients with the obstructive sleep apnea syndrome received some type of treatment for sleep apnea after the initial evaluation. Thirty-one percent achieved a weight reduction of 10 percent or more; 58 percent were using airway pressurization for at least four hours per night for five nights or more per week; 15 percent underwent upperairway surgery.
Several studies have demonstrated that airway pressurization (the main medical therapy for the syndrome) can reverse hypercoagulability and hemodynamic changes and even reduce the risk of cardiovascular events. The present study was not designed or powered to address adherence with treatment or the effect of treatment on outcomes.
Nonetheless, our study demonstrated an increased risk of stroke or death from any cause among patients with the obstructive sleep apnea syndrome despite the administration of various therapies. Several explanations may account for this finding. First, it is likely that many of our patients had had untreated obstructive sleep apnea for years before seeking treatment, resulting in a prolonged exposure to cardiovascular risk. The median 3.4 years of follow-up may not have been a sufficient length of time to derive the potential cardiovascular therapeutic benefits. Second, reduced compliance with continuous positive airway pressure and limited efficacy of other treatments may have played a role in the failure of therapy to reduce the risk to baseline levels. Third, in contrast to the patients in a recent study that suggested a beneficial effect of treatment on outcomes, 25 our population was older and had a higher prevalence of cardiovascular risk factors.
neversleeps wrote:Nonetheless, our study demonstrated an increased risk of stroke or death from any cause among patients with the obstructive sleep apnea syndrome despite the administration of various therapies.
That is exactly what bothers me about this study, too, never sleeps.never sleeps wrote:What bugs me is that they say: "Nonetheless, our study demonstrated an increased risk of stroke or death from any cause among patients with the obstructive sleep apnea syndrome despite the administration of various therapies."
You read that and you assume (because this is, after all, a scientific study) the participants on cpap therapy (mentioned in the first paragraph) must have been monitored in some way in order for them to reach the determination that cpap therapy was one of the various therapies that had no effect on stroke risk.
rested gal wrote:Yet the researchers go on to conclude this!!:
"Nonetheless, our study demonstrated an increased risk of stroke or death from any cause among patients with the obstructive sleep apnea syndrome despite the administration of various therapies."